Price movement over the last 24 hours
Acadia Healthcare Company Inc vs GE Vernova Inc — how do they compare? Acadia Healthcare Company Inc trades at $30.76 (market cap $2.94B), while GE Vernova Inc trades at $1,088.02 (market cap $289.43B). The key difference: GE Vernova Inc is far larger — about 98.4× Acadia Healthcare Company Inc's market cap, and GE Vernova Inc pays a 0.19% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | GEV | |
|---|---|---|
Market Cap | $2.94B | $289.43B |
Sector | Health | Technology |
52-Week High | $31.92 | $1.17K |
52-Week Low | $11.68 | $530.00 |
Enterprise Value | $5.45B | $282.07B |
Dividend Yield | — | 0.19% |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
GE Vernova (GEV) trades at $1,152.04, up 3.5% with strong bullish technical signals and robust fundamentals. The stock shows impressive profitability with 23.81% net margin and 83.23% ROE, though valuations appear elevated with P/E of 33.67. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q2 2026 estimates await. The company benefits from AI infrastructure demand, with gas turbines powering data centers driving growth.
Outlook remains positive given AI-driven power infrastructure demand and raised 2026 guidance, but premium valuation and execution risks warrant caution. Analyst consensus strongly favors buying with $1,220 price target, representing 6% upside. Key risks include valuation sensitivity and competitive pressures in energy transition markets.
Trailing returns across standard periods
Latest headlines on both assets
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →